Literature DB >> 20080860

Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier.

V Tardy1, R Menassa, V Sulmont, A Lienhardt-Roussie, C Lecointre, R Brauner, M David, Y Morel.   

Abstract

CONTEXT: Steroid 21-hydroxylase deficiency is the most common enzymatic defect causing congenital adrenal hyperplasia with genotype/phenotype relationships for common mutations. Novel mutations of the CYP21A2 gene must be well studied to propose right genetic counseling for patients.
OBJECTIVE: Thirteen CYP21 mutations have been studied. A detailed description of phenotype was performed for all mutations (p.I77T, p.L167P, p.I230T, p.R233K, p.G291S, p.G292D, p.E320K, p.R341P, p.R354H, p.R369W, p.R408C, p.G424S, and p.R426H). In vitro and in silico studies were performed only for those not previously described (p.L167P, p.I230T, p.R233K, p.G292D, p.E320K, and p.R369W).
RESULTS: Regarding phenotype, patients with 10 of these mutations had a classical form. A patient with isolated p.I230T presented with nonclassical form and a patient with the association p.I230T + p.V281L in cis presented with a more severe phenotype. The p.R233K mutation was detected in a carrier partner. A patient with p.R369W presented with an intermediate form. Functional studies showed that all mutations except p.I230T and p.R369W decreased enzyme activity more than p.P30L: severity of p.R369W was intermediate between p.P30L and p.V281L, and finally p.I230T was less severe than p.V281L. Mutation analysis in a three-dimensional model structure of the CYP21 protein explained the observed in vitro effects, severe mutations being implicated in important functional domains of the protein.
CONCLUSION: According to phenotype and functional studies, 11 of the mutations described, except the isolated p.R369W and p.I230T, may be responsible for a severe phenotype underlying the necessity to manage children having them. The p.I230T is a nonclassical mutation, and for the p.R369W, we need more cases to precise its severity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080860     DOI: 10.1210/jc.2009-1202

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Beyond the Caster Semenya controversy: the case of the use of genetics for gender testing in sport.

Authors:  Ambroise Wonkam; Karen Fieggen; Raj Ramesar
Journal:  J Genet Couns       Date:  2010-09-08       Impact factor: 2.537

Review 2.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

3.  Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: STRUCTURE OF THE ENZYME·PROGESTERONE SUBSTRATE COMPLEX AND RATE-LIMITING C-H BOND CLEAVAGE.

Authors:  Pradeep S Pallan; Chunxue Wang; Li Lei; Francis K Yoshimoto; Richard J Auchus; Michael R Waterman; F Peter Guengerich; Martin Egli
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

Review 4.  Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update.

Authors:  Christine M Trapp; Sharon E Oberfield
Journal:  Steroids       Date:  2011-12-13       Impact factor: 2.668

Review 5.  Human cytochromes P450 in health and disease.

Authors:  Daniel W Nebert; Kjell Wikvall; Walter L Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

6.  Nonclassic congenital adrenal hyperplasia.

Authors:  Selma Feldman Witchel; Ricardo Azziz
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-30

7.  Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

Authors:  Maria I New; Moolamannil Abraham; Brian Gonzalez; Miroslav Dumic; Maryam Razzaghy-Azar; David Chitayat; Li Sun; Mone Zaidi; Robert C Wilson; Tony Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

8.  Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia.

Authors:  Shozeb Haider; Barira Islam; Valentina D'Atri; Miriam Sgobba; Chetan Poojari; Li Sun; Tony Yuen; Mone Zaidi; Maria I New
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

9.  A Case of Salt-Wasting Congenital Adrenal Hyperplasia with Triple Homozygous Mutation: Review of Literature.

Authors:  Maria Laura Iezzi; Gaia Varriale; Luca Zagaroli; Stefania Lasorella; Marco Greco; Giulia Iapadre; Alberto Verrotti
Journal:  J Pediatr Genet       Date:  2020-03-09

10.  Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients.

Authors:  Carolina Minutolo; Alejandro D Nadra; Cecilia Fernández; Melisa Taboas; Noemí Buzzalino; Bárbara Casali; Susana Belli; Eduardo H Charreau; Liliana Alba; Liliana Dain
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.